Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04298944 · ClinicalTrials.gov registry record
Association of Mood With Risk for Atherosclerosis
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 37
- Enrollment target
NCT04298944: Completed study, sponsored by Johns Hopkins University.
NCT04298944 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04298944 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The investigators will aim to determine the association of mood disorders (MDO) with preclinical and clinical cardiovascular (CVD) risk factors among children. The investigators will also aim to identify traditional and non traditional predictors of CVD risk among children with MDO.
Primary Outcome
This will be determined from Pulse wave velocity (m/sec) done at the study visit
Interventions
- DIAGNOSTIC_TEST Cardiovascular Assessments
- DIAGNOSTIC_TEST Actigraphy
- DIAGNOSTIC_TEST Laboratory assessments
- BEHAVIORAL Emotional/ Behavioural assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2022-05-31 |
What the finished NCT04298944 record still lists
NCT04298944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Cardiovascular Assessments is the first listed.
NCT04298944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04298944 about?
NCT04298944 is a clinical study titled "Association of Mood With Risk for Atherosclerosis". The investigators will aim to determine the association of mood disorders (MDO) with preclinical and clinical cardiovascular (CVD) risk factors among children. The investigators will also aim to identify traditional and non traditional predictors of CVD risk among children with MDO.
What is the current status of trial NCT04298944?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2020-03-11. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04298944?
The interventions under investigation include: Cardiovascular Assessments (DIAGNOSTIC_TEST), Actigraphy (DIAGNOSTIC_TEST), Laboratory assessments (DIAGNOSTIC_TEST), Emotional/ Behavioural assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT04298944?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI